--- title: DeepCyte - Predict and Explain Human Toxicity description: De-Risk Drug Toxicity. DeepCyte’s AI-powered single-cell metabolomics to predicts toxicity with 94% accuracy. Request a Risk-Free 5 Compound Tox Test today. --- [Try Deetox Free →Demo →](https://demo.deepcyte.bio#lead-form) [The Problem](https://demo.deepcyte.bio#problem) [Our Solution](https://demo.deepcyte.bio#solution) [Technology](https://demo.deepcyte.bio#technology) [Compare](https://demo.deepcyte.bio#compare) [Request a Demo](https://demo.deepcyte.bio#lead-form) ![](https://demo.deepcyte.bio/hubfs/images/hero-cells.webp) # Accelerate Toxicity Screening: Test Up to 5 Compounds Risk-Free (Free Report Included) Moving from discovery to clinical trials requires absolute certainty. For a limited time, **DeepCyte is offering Biotech, Pharma, and CRO teams a zero-cost proof of concept**. Send us up to **5 of your leading molecules or compounds**, and we will evaluate them using our **AI-powered Single-Cell Metabolomics platform**. Experience firsthand how deep, single-cell metabolic profiling delivers unparalleled precision **for drug safety and toxicity screening**—before you commit. ## What You'll Receive: Comprehensive DeeTox Toxicity & Mechanistic Insight Report ![Preview of the DeeTox toxicity and mechanistic insight report](https://demo.deepcyte.bio/hubfs/images/DeepCyte%20DeeTox%20Sample%20Report.png) Request Free Tox Screening for up to 5 Compounds See DeeTox in action with your compound class. First name\* Last name\* Company email\* Job title\* Company name\* Message / Research interests Leave this field empty Request Your Free Tox Screening \*necessary field --- In today's high-stakes pharmaceutical landscape, 9 out of 10 drugs fail to reach the market. The primary "silent saboteur" is toxicity, which accounts for 30% of all program terminations. These failures represent a staggering $2.6 billion gamble that typically ends in a "no" because existing tools provide data that is too shallow, too late, and lacks mechanistic explanation. DeepCyte is bridging this resolution gap. Our proprietary single-cell metabolomics technology — refined through 10+ years of R&D — offers 1,000× the information content of conventional molecular methods. Complementing and outperforming legacy assays and other predictive tools, DeepCyte builds AI to predict and explain exactly how a drug causes toxicity at the cellular level. ![](https://demo.deepcyte.bio/hubfs/images/abstract-intro.webp) Why DeepCyte Is the Strategic Choice ### Mechanistic Clarity We provide the "why" behind every prediction, identifying toxicity mechanisms following the Adverse Outcome Pathways framework. ### Early De-risking Detect molecular shifts at sublethal concentrations, allowing you to identify and deconvolve co-existing toxicity types triggered by the same compound long before they manifest as cytotoxicity or clinical features. --- ![](https://demo.deepcyte.bio/hubfs/images/problem-abstract.webp) The Problem ## Challenge We Address Drug development faces a crisis. Despite billions invested, most compounds fail — and toxicity is the silent killer. 88% of drugs entering clinical trials never reach patients 30% of failures are linked to safety concerns discovered too late $780M+ in R&D funding lost per program due to toxicity failures --- Our solution ## DeeTox, Single-Cell advantages of the technology. ![](https://demo.deepcyte.bio/hubfs/images/solution-gradient.png) ### Explainable Predictive Toxicology Our AI reveals the biological "why" behind every toxicity prediction — delivering mechanistic insight, not just a risk score. ### Metabolic Network Mapping Our AI detects shifts in metabolic markers and connects predictions to their biological causes. ### Sublethal Detection Identify toxicity at concentrations before they become lethal, catching problems earlier in development. --- ![](https://demo.deepcyte.bio/hubfs/images/abstract-technology.webp) ## The Technology Behind the Breakthrough Two revolutionary platforms working in concert to transform drug safety prediction MetaCore™ ### The Foundation High-throughput platform processing 100,000+ cells from 100+ samples in under 10h. Best in class in reproducibility, coverage, throughput. - **Ultra-high throughput single-cell analysis** - **Cost-effective metabolomics profiling** - **Rapid turnaround for decision-making** DeeTox ### The Solution Single-cell mechanistic AI delivering unprecedented insights into toxicity mechanisms. - **Sublethal Detection** Predict AOP toxicity pathways before they become lethal, identifying risks at the earliest possible stage. - **Deconvolution** Separate co-existing AOP toxicity pathways triggered by the same compound for precise understanding. - **Mechanistic Clarity** Reveal the specific molecular rewiring triggered by your drug, enabling rational optimization. --- ## How DeepCyte Compares See the advantages of AI-powered single-cell metabolomics. Feature Animal Testing High Throughput Screening QSAR Cell Painting DeeTox FeatureHuman Relevance Animal TestingLimited (species differences) High Throughput ScreeningHigh QSARModel-dependent Cell PaintingHigh DeeToxHigh FeatureSingle-Cell Resolution Animal TestingNo High Throughput ScreeningNo QSARN/A Cell PaintingYes (emerging) DeeToxYes (deconvolves cell subpopulations) FeatureMechanistic “Why” Animal TestingYes (requires follow-up studies) High Throughput ScreeningYes (assay-dependent) QSARYes (structure-based prediction) Cell PaintingYes (morphological) DeeToxYes (biochemical) FeatureMolecular Insights Animal TestingYes (requires dedicated bioanalysis) High Throughput ScreeningYes (per target) QSARPredicted (in silico) Cell PaintingIndirect (image-derived features) DeeToxYes (endogenous metabolites) FeatureLabel-Free Measurements Animal TestingMixed High Throughput ScreeningNo QSARN/A Cell PaintingNo DeeToxYes FeatureSublethal Sensitivity Animal TestingYes (costly, late-stage) High Throughput ScreeningAssay-dependent QSARModel-dependent Cell PaintingYes (morphological) DeeToxYes (biochemical) FeatureThroughput Animal TestingLow High Throughput ScreeningVery high QSARVery high Cell PaintingHigh DeeToxModerate FeatureStage of Use Animal TestingRegulatory High Throughput ScreeningEarly discovery / Regulatory QSAREarly discovery Cell PaintingEarly discovery / Emerging regulatory DeeToxEarly discovery Request a Demo ## Interested in trying DeeTox through our Early Access Program? [Try DeeTox Demo→](https://demo.deepcyte.bio#lead-form) ![](https://demo.deepcyte.bio/hubfs/images/footer-beam.webp) [![DeepCyte](https://demo.deepcyte.bio/hubfs/images/footer-logo.png)](https://demo.deepcyte.bio#top) ### Toxicity, seen as never before. Technology and models built for this, from the ground up. DeepCyte Inc, USA DeepCyte ApS, Denmark © 2026 DeepCyte [contact@deepcyte.bio](mailto:contact@deepcyte.bio) [Privacy Policy](https://www.deepcyte.bio/privacy-policy) [Terms of Use](https://www.deepcyte.bio/terms-of-use) [Cookies Policy](https://www.deepcyte.bio/cookies-policy)